Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients.
Gravina A, Gargiulo P, De Laurentiis M, Arenare L, De Placido S, Orditura M, Cinieri S, Riccardi F, Ribecco AS, Putzu C, Del Mastro L, Rossi E, Ciardiello F, Di Rella F, Nuzzo F, Pacilio C, Caputo R, Cianniello D, Forestieri V, Giuliano M, Arpino G, Orlando L, Mocerino C, Schettino C, Piccirillo MC, Gallo C, Perrone F. Gravina A, et al. Among authors: piccirillo mc. ESMO Open. 2025 Jan 3;10(1):104085. doi: 10.1016/j.esmoop.2024.104085. Online ahead of print. ESMO Open. 2025. PMID: 39754976 Free article.
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941].
Arenare L, Di Liello R, De Placido P, Gridelli C, Morabito A, Pignata S, Nuzzo F, Avallone A, Maiello E, Gargiulo P, Schettino C, Gravina A, Gallo C, Chiodini P, Di Maio M, Perrone F, Piccirillo MC. Arenare L, et al. Among authors: piccirillo mc. ESMO Open. 2024 Nov;9(11):103693. doi: 10.1016/j.esmoop.2024.103693. Epub 2024 Oct 18. ESMO Open. 2024. PMID: 39617531 Free PMC article. No abstract available.
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: piccirillo mc. Lancet Reg Health Eur. 2024 Sep 2;44:101012. doi: 10.1016/j.lanepe.2024.101012. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444700 Free PMC article.
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA. Piccirillo MC, et al. J Thorac Oncol. 2024 Nov;19(11):1578-1579. doi: 10.1016/j.jtho.2024.08.017. Epub 2024 Aug 24. J Thorac Oncol. 2024. PMID: 39186030 No abstract available.
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study.
Caminiti C, Maglietta G, Arenare L, Di Liello R, Migliaccio G, Barberio D, De Laurentiis M, Di Rella F, Nuzzo F, Pacilio C, Iodice G, Orditura M, Ciardiello F, Di Bella S, Cavanna L, Porta C, Giovanardi F, Ripamonti CI, Bilancia D, Aprile G, Ruelle T, Diodati F, Piccirillo MC, Iannelli E, Pinto C, Perrone F. Caminiti C, et al. Among authors: piccirillo mc. Breast. 2024 Oct;77:103781. doi: 10.1016/j.breast.2024.103781. Epub 2024 Jul 20. Breast. 2024. PMID: 39059033 Free PMC article.
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Domenico Beretta G, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: piccirillo mc. Lancet Reg Health Eur. 2024 Jun 24;42:100973. doi: 10.1016/j.lanepe.2024.100973. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. Retraction in: Lancet Reg Health Eur. 2024 Sep 02;44:101012. doi: 10.1016/j.lanepe.2024.101012 PMID: 39036543 Free PMC article. Retracted.
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: piccirillo mc. Lancet Reg Health Eur. 2024 May 21;42:100940. doi: 10.1016/j.lanepe.2024.100940. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 38813536 Free PMC article.
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: piccirillo mc. Lancet Reg Health Eur. 2024 Apr 22;41:100912. doi: 10.1016/j.lanepe.2024.100912. eCollection 2024 Jun. Lancet Reg Health Eur. 2024. PMID: 38665620 Free PMC article.
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.
Arenare L, Di Liello R, De Placido P, Gridelli C, Morabito A, Pignata S, Nuzzo F, Avallone A, Maiello E, Gargiulo P, Schettino C, Gravina A, Gallo C, Chiodini P, Di Maio M, Perrone F, Piccirillo MC. Arenare L, et al. Among authors: piccirillo mc. ESMO Open. 2024 Mar;9(3):102941. doi: 10.1016/j.esmoop.2024.102941. Epub 2024 Mar 6. ESMO Open. 2024. PMID: 38452437 Free PMC article.
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
Arenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Vaccaro MC, Frontini L, Giannarelli D, Bryce J, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F. Arenare L, et al. Among authors: piccirillo mc. ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5. ESMO Open. 2023. PMID: 38052104 Free PMC article.
110 results